Lu Dai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lu Dai has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Zhiqiang Qin
Department of Pathology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, USA
10 shared publications Yueyu Cao
Department of Pediatrics, Research Center for Translational Medicine and Key Laboratory of Arrhythmias, East Hospital, Tongji University School of Medicine, Shanghai, China
4 shared publications- Besim Ogretmen
Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, USA
2 shared publications - Can E. Senkal
Department of Cellular, Molecular, and Genetic Medicine, Virginia Commonwealth University School of Medicine, Richmond, USA
2 shared publications - Charles D. Smith
Department of Neurology, Magnetic Resonance Imaging and Spectroscopy Center, University of Kentucky College of Medicine, Lexington 40536, USA
2 shared publications Chris Parsons
2 shared publications
Latest Publications
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from Targeting Sphingosine Kinase Induces Apoptosis and Tumor Regression for KSHV-Associated Primary Effusion Lymphoma
PDF file - 53K, Primer sequences for qRT-PCR in this study.
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from Targeting Sphingosine Kinase Induces Apoptosis and Tumor Regression for KSHV-Associated Primary Effusion Lymphoma
PDF file - 53K, Primer sequences for qRT-PCR in this study.
- 24 March 2020
- Published by Taylor & Francis in Future Oncology
- Vol. 16 (13) , 827-835
Serum Level of Long Noncoding RNA B3GALT5-AS1 as a Diagnostic Biomarker of Colorectal Cancer
Aim: Long noncoding RNA (lncRNA) B3GALT5-AS1 has been reported as a biomarker for cancer monitoring. This research aims to identify serum long noncoding RNA B3GALT5-AS1 as a new biomarker for the diagnosis of colorectal cancer (CRC) and evaluate its clinical value. Materials & methods: Serum B3GALT5-AS1 expression levels were measured by quantitative real-time PCR. Results: The level of B3GALT5-AS1 in CRC patients was significantly lower than that of healthy patients (p < 0.0001). Further exploration validated that high serum B3GALT5-AS1 level was related to tumor node metastasis (TNM) stage (p = 0.008) and histological differentiation (p = 0.027). Compared with the healthy control group, AUCROC of serum B3GALT5-AS1 in the CRC group was 0.762 with 95% CI: 0.698-0.826 (p < 0.0001). Conclusion: B3GALT5-AS1 may be served as a diagnostic marker for distinguishing CRC patients from healthy people.
- 24 March 2020
- Published by Taylor & Francis in Future Oncology
- Vol. 16 (13) , 827-835
Serum Level of Long Noncoding RNA B3GALT5-AS1 as a Diagnostic Biomarker of Colorectal Cancer
Aim: Long noncoding RNA (lncRNA) B3GALT5-AS1 has been reported as a biomarker for cancer monitoring. This research aims to identify serum long noncoding RNA B3GALT5-AS1 as a new biomarker for the diagnosis of colorectal cancer (CRC) and evaluate its clinical value. Materials & methods: Serum B3GALT5-AS1 expression levels were measured by quantitative real-time PCR. Results: The level of B3GALT5-AS1 in CRC patients was significantly lower than that of healthy patients (p < 0.0001). Further exploration validated that high serum B3GALT5-AS1 level was related to tumor node metastasis (TNM) stage (p = 0.008) and histological differentiation (p = 0.027). Compared with the healthy control group, AUCROC of serum B3GALT5-AS1 in the CRC group was 0.762 with 95% CI: 0.698-0.826 (p < 0.0001). Conclusion: B3GALT5-AS1 may be served as a diagnostic marker for distinguishing CRC patients from healthy people.
- 15 July 2018
- Published by American Society for Microbiology in Journal of Virology
- Vol. 92 (14)
Regulation of Virus-Associated Lymphoma Growth and Gene Expression by Bacterial Quorum-Sensing Molecules
Kaposi's sarcoma-associated herpesvirus (KSHV) can cause several human cancers, including primary effusion lymphoma (PEL), which frequently occur in immunocompromised patients. KSHV-infected patients often suffer from polymicrobial infections caused by opportunistic bacterial pathogens. Therefore, it is crucial to understand how these coinfecting microorganisms or their secreted metabolites may affect KSHV infection and the pathogenesis of virus-associated malignancies. Quorum sensing (QS), a cell density-based intercellular communication system, employs extracellular diffusible signaling molecules to regulate bacterial virulence mechanisms in a wide range of bacterial pathogens, such as Pseudomonas aeruginosa , which is one of the most common opportunistic microorganisms found in immunocompromised individuals. In this study, we evaluated and compared the influence on PEL growth and the host/viral interactome of the major QS signaling molecules [ N -(3-oxododecanoyl)- l -homoserine lactone (OdDHL), N -butyrylhomoserine lactone (BHL), and 2-heptyl-3-hydroxy-4-quinolone (PQS)] in conditioned medium from wild-type (wt) and QS mutant laboratory strains as well as clinical isolates of P. aeruginosa . Our data indicate that P. aeruginosa coinfection may facilitate virus dissemination and establishment of new infection and further promote tumor development through effectively inducing viral lytic gene expression by its QS systems. IMPORTANCE Currently, most studies about KSHV infection and/or virus-associated malignancies depend on pure culture systems or immunodeficient animal models. However, the real situation should be much more complicated in KSHV-infected immunocompromised patients due to frequent polymicrobial infections. It is important to understand the interaction of KSHV and coinfecting microorganisms, especially opportunistic bacterial pathogens. Here we report for the first time that P. aeruginosa and its quorum-sensing signaling molecules display a complicated impact on KSHV-associated lymphoma growth as well as the intracellular host/viral gene expression profile. Our data imply that targeting of coinfecting pathogens is probably necessary during treatment of virus-associated malignancies in these immunocompromised patients.
- 15 July 2018
- Published by American Society for Microbiology in Journal of Virology
- Vol. 92 (14)
Regulation of Virus-Associated Lymphoma Growth and Gene Expression by Bacterial Quorum-Sensing Molecules
Kaposi's sarcoma-associated herpesvirus (KSHV) can cause several human cancers, including primary effusion lymphoma (PEL), which frequently occur in immunocompromised patients. KSHV-infected patients often suffer from polymicrobial infections caused by opportunistic bacterial pathogens. Therefore, it is crucial to understand how these coinfecting microorganisms or their secreted metabolites may affect KSHV infection and the pathogenesis of virus-associated malignancies. Quorum sensing (QS), a cell density-based intercellular communication system, employs extracellular diffusible signaling molecules to regulate bacterial virulence mechanisms in a wide range of bacterial pathogens, such as Pseudomonas aeruginosa , which is one of the most common opportunistic microorganisms found in immunocompromised individuals. In this study, we evaluated and compared the influence on PEL growth and the host/viral interactome of the major QS signaling molecules [ N -(3-oxododecanoyl)- l -homoserine lactone (OdDHL), N -butyrylhomoserine lactone (BHL), and 2-heptyl-3-hydroxy-4-quinolone (PQS)] in conditioned medium from wild-type (wt) and QS mutant laboratory strains as well as clinical isolates of P. aeruginosa . Our data indicate that P. aeruginosa coinfection may facilitate virus dissemination and establishment of new infection and further promote tumor development through effectively inducing viral lytic gene expression by its QS systems. IMPORTANCE Currently, most studies about KSHV infection and/or virus-associated malignancies depend on pure culture systems or immunodeficient animal models. However, the real situation should be much more complicated in KSHV-infected immunocompromised patients due to frequent polymicrobial infections. It is important to understand the interaction of KSHV and coinfecting microorganisms, especially opportunistic bacterial pathogens. Here we report for the first time that P. aeruginosa and its quorum-sensing signaling molecules display a complicated impact on KSHV-associated lymphoma growth as well as the intracellular host/viral gene expression profile. Our data imply that targeting of coinfecting pathogens is probably necessary during treatment of virus-associated malignancies in these immunocompromised patients.
- Open Access
- 1 January 2018
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 9 (23) , 4503-4509
Ribonucleotide Reductase Inhibitor 3-AP Induces Oncogenic Virus Infected Cell Death and Represses Tumor Growth
Kaposi's Sarcoma-associated Herpesvirus (KSHV) is the etiologic agent of several human malignancies, particularly Kaposi's Sarcoma (KS), which preferentially arise in immunocompromised patients such as HIV+ subpopulation while still lacking of effective therapeutic options. We recently found that the ribonucleotide reductase (RR) subunit M2 is potentially regulated by the key oncogenic HGF/c-MET pathway in KSHV-related lymphoma cells. One of RR inhibitor, 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) effectively induced apoptosis of KSHV+ lymphomas and suppressed tumor progression in vivo. In the current study, we found that 3-AP treatment selectively inhibited the proliferation of KSHV-infected endothelial cells, the major cellular components of KS, through inducing DNA damage, reducing the levels of intracellular iron and reactive oxygen species (ROS) and increasing viral lytic gene expression. By using a KS-like nude mouse model, we found that 3-AP treatment significantly suppressed KSHV induced tumorigenesis in vivo. Taken together, our data demonstrate targeting RR by 3-AP may represent a promising strategy for improving the treatment of KS in future.
- 1 January 2018
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 9 (23) , 4503-4509
Open AccessRibonucleotide Reductase Inhibitor 3-AP Induces Oncogenic Virus Infected Cell Death and Represses Tumor Growth
Kaposi's Sarcoma-associated Herpesvirus (KSHV) is the etiologic agent of several human malignancies, particularly Kaposi's Sarcoma (KS), which preferentially arise in immunocompromised patients such as HIV+ subpopulation while still lacking of effective therapeutic options. We recently found that the ribonucleotide reductase (RR) subunit M2 is potentially regulated by the key oncogenic HGF/c-MET pathway in KSHV-related lymphoma cells. One of RR inhibitor, 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) effectively induced apoptosis of KSHV+ lymphomas and suppressed tumor progression in vivo. In the current study, we found that 3-AP treatment selectively inhibited the proliferation of KSHV-infected endothelial cells, the major cellular components of KS, through inducing DNA damage, reducing the levels of intracellular iron and reactive oxygen species (ROS) and increasing viral lytic gene expression. By using a KS-like nude mouse model, we found that 3-AP treatment significantly suppressed KSHV induced tumorigenesis in vivo. Taken together, our data demonstrate targeting RR by 3-AP may represent a promising strategy for improving the treatment of KS in future.
- 10 October 2017
- Published by Elsevier in Virologica Sinica
- Vol. 32 (5) , 369-375
Lipids, lipid metabolism and Kaposi’s sarcoma-associated herpesvirus pathogenesis
- 10 October 2017
- Published by Elsevier in Virologica Sinica
- Vol. 32 (5) , 369-375
Lipids, lipid metabolism and Kaposi’s sarcoma-associated herpesvirus pathogenesis
- Open Access
- 27 January 2017
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (9) , 15220-15229
Up-regulation of tumor suppressor genes by exogenous dhC16-Cer contributes to its anti-cancer activity in primary effusion lymphoma
Up-regulation of tumor suppressor genes by exogenous dhC16-Cer contributes to its anti-cancer activity in primary effusion lymphoma
- 27 January 2017
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (9) , 15220-15229
Open AccessUp-regulation of tumor suppressor genes by exogenous dhC16-Cer contributes to its anti-cancer activity in primary effusion lymphoma
Up-regulation of tumor suppressor genes by exogenous dhC16-Cer contributes to its anti-cancer activity in primary effusion lymphoma
- Open Access
- 1 June 2016
- Published by Elsevier in Genomics Data
- Vol. 8, 16-17
Genomic analysis of xCT-regulatory network in KSHV + primary effusion lymphomas
- 1 June 2016
- Published by Elsevier in Genomics Data
- Vol. 8, 16-17
Open AccessGenomic analysis of xCT-regulatory network in KSHV + primary effusion lymphomas
- 14 July 2015
- Published by Georg Thieme Verlag KG in Pneumologie
- Vol. 69 (07) , A30
Airway surface dehydration is a novel risk factor for allergic airway inflammation
Introduction: We have previously demonstrated that mice with airway specific overexpression of the amiloride-sensitive epithelial Na+ channel (βENaC-Tg) and mice lacking the epithelial Cl- channel SLC26A9 suffer from airway surface dehydration and airway mucus obstruction, which might be implicated in the pathogenesis of allergic airway disease (Anagnostopoulou et al., JCI 2012 and Mall et al., AmJRespirCritCare Med 2008). Here, we hypothesized that airway surface dehydration and reduced mucociliary clearance may increase the susceptibility for allergic airway inflammation. Methods: Aspergillus fumigatus extract (Af) was applied by intratracheal instillations into juvenile βENaC-Tg mice or WT mice (C57BL/6) and BAL cell counts, IL-13 levels and airway hyperresponsiveness (AHR, by Flexivent lung function) were determined. Genetic deletion of the IL-4/IL13 receptor signal transducer STAT6 was introduced to βENaC-Tg mice to analyze the contribution of type 2 inflammation to the Af immune response. Furthermore, preventive treatment of βENaC-Tg mice and WT mice with amiloride was performed and BAL and IL-13 levels were determined. Results: Airway eosinophils and pulmonary IL-13 expression were significantly increased in Af-challenged compared to vehicle-treated βENaC-Tg mice. Airway hyperresponsiveness was elevated in βENaC-Tg mice and increased further in response to Af treatment. Genetic deletion of STAT6 abrogated Af-induced airway eosinophilia and IL-13 expression in βENaC-Tg mice. Preventive treatment with amiloride significantly reduced allergic inflammataion in both βENaC-Tg and WT mice. Conclusion: Collectively, our results indicate that airway surface dehydration is a risk factor for key pathologies in allergic airway disease. Amelioration of airway surface dehydration (i.e. by amiloride) might constitute a novel target for prevention and treatment of allergic airway disease. Acknowledgements: DFG (DFG MA 2081/3 – 2) *Presenting author
- 14 July 2015
- Published by Georg Thieme Verlag KG in Pneumologie
- Vol. 69 (07) , A30
Airway surface dehydration is a novel risk factor for allergic airway inflammation
Introduction: We have previously demonstrated that mice with airway specific overexpression of the amiloride-sensitive epithelial Na+ channel (βENaC-Tg) and mice lacking the epithelial Cl- channel SLC26A9 suffer from airway surface dehydration and airway mucus obstruction, which might be implicated in the pathogenesis of allergic airway disease (Anagnostopoulou et al., JCI 2012 and Mall et al., AmJRespirCritCare Med 2008). Here, we hypothesized that airway surface dehydration and reduced mucociliary clearance may increase the susceptibility for allergic airway inflammation. Methods: Aspergillus fumigatus extract (Af) was applied by intratracheal instillations into juvenile βENaC-Tg mice or WT mice (C57BL/6) and BAL cell counts, IL-13 levels and airway hyperresponsiveness (AHR, by Flexivent lung function) were determined. Genetic deletion of the IL-4/IL13 receptor signal transducer STAT6 was introduced to βENaC-Tg mice to analyze the contribution of type 2 inflammation to the Af immune response. Furthermore, preventive treatment of βENaC-Tg mice and WT mice with amiloride was performed and BAL and IL-13 levels were determined. Results: Airway eosinophils and pulmonary IL-13 expression were significantly increased in Af-challenged compared to vehicle-treated βENaC-Tg mice. Airway hyperresponsiveness was elevated in βENaC-Tg mice and increased further in response to Af treatment. Genetic deletion of STAT6 abrogated Af-induced airway eosinophilia and IL-13 expression in βENaC-Tg mice. Preventive treatment with amiloride significantly reduced allergic inflammataion in both βENaC-Tg and WT mice. Conclusion: Collectively, our results indicate that airway surface dehydration is a risk factor for key pathologies in allergic airway disease. Amelioration of airway surface dehydration (i.e. by amiloride) might constitute a novel target for prevention and treatment of allergic airway disease. Acknowledgements: DFG (DFG MA 2081/3 – 2) *Presenting author
- Open Access
Role of Host MicroRNAs in Kaposi’s Sarcoma-Associated Herpesvirus Pathogenesis
MicroRNAs (miRNAs) are small non-coding RNA species that can bind to both untranslated and coding regions of target mRNAs, causing their degradation or post-transcriptional modification. Currently, over 2500 miRNAs have been identified in the human genome. Burgeoning evidence suggests that dysregulation of human miRNAs can play a role in the pathogenesis of a variety of diseases, including cancer. In contrast, only a small subset of human miRNAs has been functionally validated in the pathogenesis of oncogenic viruses, in particular, Kaposi’s sarcoma-associated herpesvirus (KSHV). KSHV is the etiologic agent of several human cancers, such as primary effusion lymphoma (PEL) and Kaposi’s sarcoma (KS), which are mostly seen in acquired immune deficiency syndrome (AIDS) patients or other immuno-suppressed subpopulation. This review summarizes recent literature outlining mechanisms for KSHV/viral proteins regulation of cellular miRNAs contributing to viral pathogenesis, as well as recent findings about the unique signature of miRNAs induced by KSHV infection or KSHV-related malignancies.
Open AccessRole of Host MicroRNAs in Kaposi’s Sarcoma-Associated Herpesvirus Pathogenesis
MicroRNAs (miRNAs) are small non-coding RNA species that can bind to both untranslated and coding regions of target mRNAs, causing their degradation or post-transcriptional modification. Currently, over 2500 miRNAs have been identified in the human genome. Burgeoning evidence suggests that dysregulation of human miRNAs can play a role in the pathogenesis of a variety of diseases, including cancer. In contrast, only a small subset of human miRNAs has been functionally validated in the pathogenesis of oncogenic viruses, in particular, Kaposi’s sarcoma-associated herpesvirus (KSHV). KSHV is the etiologic agent of several human cancers, such as primary effusion lymphoma (PEL) and Kaposi’s sarcoma (KS), which are mostly seen in acquired immune deficiency syndrome (AIDS) patients or other immuno-suppressed subpopulation. This review summarizes recent literature outlining mechanisms for KSHV/viral proteins regulation of cellular miRNAs contributing to viral pathogenesis, as well as recent findings about the unique signature of miRNAs induced by KSHV infection or KSHV-related malignancies.